GlassScriptPhysician profile
Rob Xavier Cruz
NPI 1700598505
$1,091.23
in general payments reported to CMS, 2019-2025
16 companies · $16.65 in 2025
The $16.65 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,045 · 2024: $29.85 · 2025: $16.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,091.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $268.12 | 2023-2025 | |
| Lilly USA, LLC | $125.20 | 2023 | Mounjaro, Trulicity, Emgality |
| Novo Nordisk INC | $100.70 | 2023 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.98 | 2023 | Xifaxan |
| Janssen Pharmaceuticals, INC | $86.93 | 2023 | Xarelto, Spravato |
| Astrazeneca Pharmaceuticals LP | $64.52 | 2023 | Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $63.38 | 2023 | |
| Exact Sciences Corporation | $59.89 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $46.83 | 2023 | Shingrix, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $42.21 | 2023 | Gardasil 9, Vaxneuvance, Proquad |
| Pfizer INC. | $36.06 | 2023 | |
| Novavax INC | $35.95 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Sanofi Pasteur INC. | $21.97 | 2023 | |
| Novartis Pharmaceuticals Corporation | $19.09 | 2023 | |
| Phadia US INC. | $16.68 | 2023 | Immunocap |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $13.72 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rob Xavier Cruz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.